CSII Key Stats
- Cardiovascular Systems (CSII) ORBIT II Trial Met Endpoints Street Insider May 23
- Cardiovascular Systems Presents New Late-Breaking Coronary Results at EuroPCR Co... May 23
- Nasdaq stocks posting largest percentage increases May 20
- Cardiovascular Systems Releasing Late-Breaking ORBIT II Coronary Data at EuroPCR... May 20
- Tuesday 5/14 Insider Buying Report: CSII, POL May 14
- Cardiovascular's CEO Discusses F3Q2013 Results - Earnings Call Transcript Seeking Alpha May 1
- Cardiovascular Systems, Inc. Earnings Call scheduled for 4:45 pm ET today May 1
- Cardiovascular Systems Reports Fiscal 2013 Third-Quarter Financial Results Business Wire May 1
- Q3 2013 Cardiovascular Systems, Inc. Earnings Release - After Market Close May 1
- Cardiovascular Systems Confirms U.S. Information Request Apr 30
CSII Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Cardiovascular Systems is up 105.0% over the last year vs S&P 500 Total Return up 28.33%, Boston Scientific up 54.29%, and Spectranetics Corporation up 96.14%.
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Income Statement View Statement
Pro Ratings for CSII
Pro Report PDF for CSII
Download Pro Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.Download CSII Pro Report PDF
Pro Strategies Featuring CSII
Did Cardiovascular Systems make it into our Pro Portfolio Strategies?